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Wereporttwocasesofseverepostsphincterotomybleedinginanadultandapediatricpatienttreated,asﬁrstoptions,withavailable
techniques to induce hemostasis without success. Because of persisting bleeding, an expandable, partially covered, metallic stent
was placed into the choledocho to mechanically compress the bleeding site. The bleeding was stopped. In the following days,
both patients remained hemodynamically stable with no further episodes of bleeding. We believe that the application of a covered
metallic stent in a severe postendoscopic-sphincterotomy bleeding, refractory to injection therapy, should be considered to avoid
additional interventions, which carry a higher risk of complications, even in pediatric patients.
1.Introduction
Endoscopic retrograde cholangiopancreatography (ERCP)
has become an important therapeutic procedure for a great
varietyofbiliaryandpancreaticdiseases[1].Sphincterotomy
is used to remove biliary and pancreatic stones, to facilitate
placement of biliary and pancreatic stents, and to treat
patients with sphincter-of-Oddi dysfunction [2]. One of the
most frequent complications of sphincterotomy is bleeding
[3, 4]. We report two cases of use of a covered metallic stent
to treat severe postsphincterotomy bleeding.
2.CaseReport 1
A 52-year-old man underwent laparoscopic cholecystectomy
in 2002. Since then, the patient has had recurrent episodes of
abdominal pain and fever. An ERCP was performed in 2004,
with sphincterotomy and sludge removal. Another episode
of cholangitis led to an additional procedure, performed
in March 2005, with pneumatic and mechanical dilation
of the sphincterotomy and sludge removal. The patient
has since experienced other episodes of cholangitis, treated
with antibiotic therapy only, the last one in July 2006,
with evidence of cholestasis and choledochus dilation at
sonography. For this reason, the patient was admitted to our
institute to undergo ERCP. The patient was in good general
condition,andphysicalexaminationwasunremarkable.Lab-
oratory data were Hb 15.3gr/dL, HCT 44%, direct bilirubin
0.68mg% gammaglutamyl transferase 281U/L, AST/ALT
42/186U/L, and alkaline phosphates 146U/L. We found
no comorbidities. On piperacillin/tazobactam, the patient
underwent ERCP, showing mild dilation of the choledochus
with several ﬁlling defects. The sphincterotomy was enlarged
with a sphincterotome on a guide wire (endocut:watt 120;
coag:watt 40, PSD 60 Olympus) and biliary sludge was
removed with a Fogarty balloon catheter. The procedure
was well tolerated and no signs of bleeding were detected.
Almost 6 hours after the procedure, the patient had an
episode of rectal bleeding. Blood tests showed Hb 13.3gr/dL,
HCT 39.3%, 120/80mmHg, and heart rate 70/min. As a
result, an emergency esophageal gastroduodenoscopy (EGD)
was performed. It showed active bleeding from the site of
previous sphincterotomy. Adrenaline was injected (1:10.000
dilution, 10mL) and a metallic clip (Resolution Clip, Boston
Scientiﬁc Corporation, Natik USA) was placed, with an
evident cessation of hemorrhaging (Figure 1). The following2 Gastroenterology Research and Practice
day, the patient had two episodes of severe rectal bleeding.
Hemoglobin levels were stable at 11.7gr/dL, Hct 35%,
arterial blood pressure was 120/70mmHg, and heart rate
was 70/min. Another EGD was performed and showed a
persistent and severe bleeding from the previous clip place-
ment site (Figure 2). Sclerosis with adrenaline (1:10.000
dilution, 10mL) was redone, and a plastic stent (10Fr, 5cm,
OASIS, Wilson Cook Medical, Winston-Salem, NC) was
placed, with subsequent cessation of the bleeding. Almost
3 hours after the sclerotherapy, the patient became hemo-
dynamically instable, hypotensive, and tachicardic, with
drop in hemoglobin level (Hb:4gr/dL). Another episode of
hematochezia occurred. EGD was repeated once more and
showed a large amount of blood and clots in the stomach,
and fresh bleeding from the sphincterotomy. The plastic
stent was removed with a snare, and multiple clots were
removed from the biliary duct with a balloon catheter,
exposing a small, nonbleeding vessel in the site of the
sphincterotomy (Figure 3). Severe bleeding occurred. In
order to stop the bleeding, an 8mm dilation balloon catheter
(8mm × 2cm Hurricane Microvasive, Boston Scientiﬁc
Corporation, Natik USA) was used to tampon the hemor-
rhage temporarily. But because of persisting of the bleeding
fromthesphincterotomysitewhentheballoonwasremoved,
an expandable, partially covered metallic stent (4cm in
length and 1cm in diameter, Wallstent, Boston Scientiﬁc
Corporation, Natik USA) was placed in the choledocho to
mechanically compress the bleeding site and drain the clots
from the biliary duct (Figure 4). The patient was admitted
to the intensive care unit. After volume replacement (almost
2L) and transfusion of 4 units of packed red blood cells,
the patient stabilized hemodynamically (Hb:8gr/dL). On
postprocedure day 5, the patient was discharged home in
good clinical condition. We saw him one month later in
the outpatient clinic. He was in good general condition,
asymptomatic, and with normal blood tests. An ERCP was
scheduled to remove the previously placed metallic stent.
The ERCP showed a partial obstruction in the metallic stent
and was removed with a snare. The cholangiography showed
multiple ﬁlling defects in the upper third of the choledocho.
No signs of bleeding were seen (Figure 5). A Fogarty balloon
catheter was used to remove the sludge. The patient was
discharged home the day after the procedure in good general
conditions, asymptomatic, and with normal blood tests.
After 8 months, the patient is still asymptomatic and in good
general conditions.
3.CaseReport 2
An 8-year-old boy was admitted to our institute because of
portal cavernoma, perhaps secondary to umbilical vessels
that were cannulated for neonatal sepsis, and esophageal
varices were treated with two sessions of banding lig-
ation. Another comorbidity found was congenital com-
bined immunodeﬁciency (SCID T-B+). During followup,
a CT scan, performed in order to evaluate his vascular
anatomy for a possible surgical shunt, showed a 6.5cm
hepatic ﬂuid lesion of unknown origin with a suspected
stone inside, mild intrahepatic biliary duct dilation, and
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Figure 1: A clip was placed at the site of the sphincterotomy.
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Figure 2: Severe bleeding from the sphincterotomy site.
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Figure 3: After clip placement and sclerosis, a vessel behind the clip
is visible (arrow).Gastroenterology Research and Practice 3
Figure 4: The metallic stent is placed.
Figure 5: No signs of bleeding after metallic stent removal.
al a r g ec a v e r n o m ao ft h ep o r t a lv e i n .L a b o r a t o r yd a t a
were AST/ALT 42/74U/L (normal:5–40/65U/L), bilirubin
tot/dir 0.49/0.11mg/dL (0–1.5mg/dL), alkaline phosphates
362U/L (40–134U/L), gamma-GT 70mg/(5–85U/L), PLT
60 10 µL (50–400 10µL), PT 84% (80%–120%), and INR
1.16 (0.80–1.20INR). With evidence of cholestasis and
a CT scan that prompted suspicion of a biliary stone,
an ERCP was planned. At admission, the patient was in
good general conditions, and the physical examination was
unremarkable (weight Kg 20, arterial blood pressure 86/52,
and heart rate 84). On piperacillin/tazobactam and under
general anesthesia, the patient, continuously monitored
with electrocardiography, pulse oximeter, and automatic
recording of blood pressure and pulse, underwent ERCP,
showing hilar extrinsic compression, with several ﬁlling
defects.Thesphincterotomywasdonewithasphincterotome
on a guide wire (endocut:watt 120; coag:watt 40, PSD 60
Olympus). Severe bleeding occurred. The lumen was ﬁlled
entirely with blood, and only after ten minutes of washout
and compression with an 8mm dilation balloon catheter
(8mm × 2cm Hurricane Microvasive, Boston Scientiﬁc
Corporation, Natik USA) and then with a stone extraction
balloon catheter (15mm, Extractor XL, Boston Scientiﬁc
Corporation, Natik USA) (Figure 6), the bleeding site was
seen in the upper margin of the sphincterotomy (Figure 7).
Severalattemptsatsclerosiswith1:10.000epinephrine, total
Figure 6: A stone extraction balloon cathether was used for
compression.
Figure 7: Severe bleeding from theupper margin of thesphinctero-
tomy site.
20mL, were injected without stopping the bleeding. The
patient became hypotensive, and hemoglobin level dropped
to 7gr/dL (from 10.4gr/dL). We immediately started volume
replacement (almost 1L) and transfusion of 450cc of packed
red blood cells. Given our previous experience with a metal
stent in post-sphincterotomy bleeding in an adult patient,
we decided, 90 minutes into the procedure, to insert an
expandable, covered metallic stent (4cm in length and 1cm
in diameter, Wallstent, Boston Scientiﬁc Corporation, Natik
USA) into the choledocho to mechanically compress the
bleeding site and simultaneously drain the biliary duct (Fig-
ure 8). The bleeding ceased and the patient was admitted to
the intensive care unit, in hemodynamically stable condition
(Hb:8.3gr/dL). On post-procedure day 5, the patient was
discharged home in good clinical conditions. Two weeks
later, he underwent an open procedure to construct a
mesocaval shunt. He tolerated this well, and 3 days later
an ERCP to remove the stent was planned. Under general
anesthesia, a lateral view endoscope was introduced and4 Gastroenterology Research and Practice
Figure 8: Expandable covered metallic stent placement.
Figure 9: The metal stent is removed with alligator-tooth forceps.
advanced to the papilla, where the stent was seen. The stent
was patent and was removed with alligator-tooth forceps
(Figure 9). The cholangiogram was normal, and no signs
of bleeding were seen (Figure 10). Now, at six months after
the procedure, the patient is in good general conditions,
asymptomatic, and without signs of cholestasis.
4. Discussion
Generally, postsphincterotomy bleeding is common (2%–
11%) and self-limiting. Irrigation with sclerosants is usually
suﬃcient to stop the bleeding [3, 4]. Other modalities
include endoscopic balloon tamponade [5], thermal therapy
with argon plasma coagulation [6], use of ﬁbrin glue,
and clip placement [7]. For refractory cases, angiographic
embolization, or surgery, is necessary [8]. Several studies
have shown that serial placement of biliary stents of incre-
mentally increasing diameter is successful in the treatment of
post-sphincterotomy stenosis. Moreover, a recent case report
documented the successful use of a covered metallic stent in
active bleeding from esophageal varices [9]. This evidence in
the literature prompted us to apply the stent in an attempt
to stop the bleeding. We used the compressive eﬀect of the
Figure 10: No signs of bleeding after stent removal.
stent in the ﬁrst case. In the second case, because we had
successfully used the stent in an adult patient to treat post-
sphincterotomy bleeding, and because patient was young,
we opted to forego the other available methods. The main
indication for the use of metal stents is biliary obstruction
[10]. Recently, use of these stents has progressively expanded
to treatment of other pathologic conditions [11, 12]. Place-
ment and removal of these stents are easy, though removal
must be done within no more than 3 months. In the ﬁrst
case, we attempted everything but embolization to stop the
bleeding. Moving the patient (intubated and in hypotensive
condition) to the angiographic room was too diﬃcult and,
indeed, dangerous. In the second case, we relied on our
previous experience in an adult patient, using a metal stent
to stop the hemorrhaging. In conclusion, we believe that
in persistent post-ES bleeding, when refractory to injection
therapy or when not all modalities to induce hemostasis
are available, the application of a covered metallic stent
should be considered a further therapeutic option, allowing
the endoscopist to avoid additional procedures, with higher
risks of complications, especially in very young patients,
who could have more serious complications. However,
further studies and new advanced metallic prostheses with
adequate features (longer length, great bile resistance, and
easy removal) are needed to ensure safe and eﬃcient use.
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